Navigation Links
Biomet® Ankle Arthrodesis Nail

ProductsBiomet® Ankle Arthrodesis Nail
Company Biomet Orthopedics, Inc
Item Biomet® Ankle Arthrodesis Nail
Features 
  • The strength and biocompatibility of titanium alloy
  • Lateral to medial transfixation locking screws
  • A load sharing fixation device that affords torsional rigidity and better calcaneal purchase through the posterior to anterior transcalcaneal locking screw
  • The option for compression with a unique nail-mounted compression device
  • Precise, reproducible instrumentation with nail-mounted targeting for the proximal and distal screws
  • For tibiotalocalcaneal or pantalar ankle fusion
  • A posterior to anterior screw provides 40% greater torsional rigidity than lateral to medial screws alone 1
  • Proven clinical results
    • Description The Biomet Ankle Arthrodesis Nail is ideally suited for tibiotalocalcaneal fusion indications. This second-generation nail affords rigid, load sharing fixation that incorporates a simple nail-mounted, in-line method of compression across the arthrodesis sites.
    Info Biomet Orthopedics, Inc
    Customer Service: (800) 348-9500
    Web site: http://www.biomet.com

    Related medicine products :

    1. Biomet® Arthrodesis Nail
    2. Buechel-Pappas™ Total Ankle System
    3. Agility Total Ankle System
    4. Ankle Arthrodesis Nail
    5. True/Fix Ankle Fusion Nail System
    6. Guhl Non-Invasive Ankle Distractor System
    7. Ankle Cryo/Cuff™
    8. Pediatric Ankle Cryo/Cuff™
    9. Air-Stirrup® Ankle Brace
    10. QualCare™ Compression Ankle Support
    11. Allsport Ankle Ortho II
    Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 1U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 2U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 3U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 4Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 1Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 1WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 3WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 4